Advertisement
Screener

REVVITY, INC (RVTY) Dividend Safety

REVVITY, INC (RVTY) Dividend Safety

  • Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-07-05..

Dividend safety

Overview →

Financial period ending 2026-07-05; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Dividend payout ratio · 12 months(m)Cash dividends paid / net income. Period ending 2026-07-05.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Dividend payments · 12 months(m)
Net income · 12 months237.55M USDNet Income (Loss) Attributable to Parent

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingDividend payments · 12 months (USD)Net income · 12 months (USD)Dividend payout
2026-07-05(m)$237.55M(m)
2026-04-05(m)$239.68M(m)
2025-12-28(m)$241.20M(m)
2025-09-28(m)$237.48M(m)
2025-06-29(m)$285.20M(m)
2025-03-30(m)$286.61M(m)
2024-12-29(m)$270.38M(m)
2024-09-29(m)$254.30M(m)
2024-06-30(m)$169.43M(m)
2024-03-31(m)$149.63M(m)
2023-12-31(m)$693.09M(m)
2023-10-01(m)$742.19M(m)
2023-07-02(m)$818.04M(m)
2023-04-02(m)$961.69M(m)
2023-01-01(m)$569.18M(m)
2022-10-02(m)$631.71M(m)
2022-07-03(m)$674.10M(m)
2022-04-03(m)$740.81M(m)
2022-01-02(m)$943.16M(m)
2021-10-03(m)$1.13B(m)
2021-07-04(m)$1.18B(m)
2021-04-04(m)$1.07B(m)
2021-01-03(m)$727.89M(m)
2020-10-04(m)$412.03M(m)
2020-07-05(m)$293.89M(m)
2020-04-05(m)$225.81M(m)
2019-12-29(m)$227.56M(m)
2019-09-29(m)$234.35M(m)
2019-06-30(m)$252.34M(m)
2019-03-31(m)$247.31M(m)
2018-12-30(m)$237.93M(m)
2018-09-30(m)$125.52M(m)
2018-07-01(m)$140.05M(m)
2018-04-01(m)$280.05M(m)
2017-12-31(m)$292.63M(m)
2017-10-01(m)$398.60M(m)
2017-07-02(m)$365.65M(m)
2017-04-02(m)$225.44M(m)
2017-01-01(m)$234.30M(m)
2016-10-02(m)$237.70M(m)
2016-07-03(m)$234.44M(m)
2016-04-03(m)$219.56M(m)
2016-01-03(m)$212.43M(m)
2015-10-04(m)$174.96M(m)
2015-06-28(m)$162.37M(m)
2015-03-29(m)$163.89M(m)
2014-12-28(m)$157.78M(m)
2014-09-28(m)$193.86M(m)
2014-06-29(m)$191.78M(m)
2014-03-30(m)$169.22M(m)
2013-12-29(m)$167.21M(m)
2013-09-29(m)$84.48M(m)
2013-06-30(m)$73.88M(m)
2013-03-31(m)$79.59M(m)
2012-12-30(m)$69.94M(m)
2012-09-30(m)$2.15M(m)
2012-07-01(m)$9.18M(m)
2012-04-01(m)$5.31M(m)
2012-01-01(m)$7.66M(m)
2011-10-02(m)$375.89M(m)
2011-07-03(m)$353.96M(m)
2011-04-03(m)$383.05M(m)
2011-01-02(m)$383.92M(m)
2010-10-03(m)(m)(m)
2010-07-04(m)(m)(m)
2010-04-04(m)(m)(m)
2010-01-03(m)$85.60M(m)
2009-10-04(m)(m)(m)
2009-07-05(m)(m)(m)
2008-12-28(m)$126.41M(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16